Physiome Sciences to Acquire Predix Pharmaceuticals | GenomeWeb

NEW YORK, Aug. 13 (GenomeWeb News) –  Physiome Sciences of Princeton, NJ, today announced that it will acquire Predix Pharmaceuticals of Woburn, Mass.

Physiome will acquire Predix in exchange for 30 percent of the combined equity of the two firms.  The combined entity will will be headquartered in Woburn, Mass., and will be named Predix Pharmaceuticals. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.